Effect of ayurvedic medicine in leucorrhoea.

Randomized Controlled Trial of Nyagrodha- Lodhra vati with Ghrita- Madhu lipta Lodhradi Yonivarti in the management of Shwetapradara W. S. R. To Leucorrhoea.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083439

Enrollment

Registered

2025-03-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age : 18 to 45 years 2) Indoor and outdoor patient having Yonigata shwetstrava 3) Married patients 4) Cervicitis- Inflammation of Cervix.

Exclusion criteria

Exclusion criteria: 1) Pregnancy 2) Neoplasia including malignancies 3) Immune compromised patient 4) Patient with other systemic disorders like vaginal tuberculosis, DM, HTN etc

Design outcomes

Primary

Measure	Time frame
To study effect of Nyagrodha- Lodhra Vati 500 mg 2 TDS with Ghrita- Madhu lipta Lodhradi Yonivarti in management of Shwetapradara w. s. r. to Leucorrhoea.Timepoint: 7 days	—

Secondary

Measure	Time frame
1. To study Shwetapradara according to Ayurved and modern science. 2. To study Nyagrodha- Lodhra Vati in detail. 3. To study Yonivarti of Lodhra, Priyangu and Madhuka, Madhu with ghrita in detail. 4. To study sign and symptoms of Shwetapradara (Leucorrhoea). Timepoint: 7 days	—

Countries

India

Contacts

Public ContactDr Saksha Dattatray Chavan

Siddhakala Ayurved Mahavidyalaya, Sangamner

vipulbhujbal1@gmail.com9960840214

Outcome results